ADVFN US – Market Content Editor

  • AI Cloud Acquisition Expands as IREN (IREN) Buys Mirantis to Boost Infrastructure Capabilities

    AI Cloud Acquisition Expands as IREN (IREN) Buys Mirantis to Boost Infrastructure Capabilities

    The deal adds enterprise software and operational expertise to support scaling AI cloud deployments. IREN Limited (NASDAQ:IREN) announced an AI cloud acquisition with a definitive agreement to acquire Mirantis for approximately $625 million in stock. The move is aimed at strengthening IREN’s ability to deploy, manage, and support large-scale AI infrastructure as demand for cloud-based…

  • PDUFA Decision Nears as Viridian Therapeutics (VRDN) Advances TED Pipeline and Reports Q1 Results

    PDUFA Decision Nears as Viridian Therapeutics (VRDN) Advances TED Pipeline and Reports Q1 Results

    Regulatory milestones and late-stage clinical progress position the company ahead of a key FDA decision in June. Viridian Therapeutics, Inc. (NASDAQ:VRDN) reported first-quarter 2026 results alongside updates on its pipeline, with a PDUFA decision for veligrotug in thyroid eye disease (TED) set for June 30, 2026. The upcoming regulatory milestone is central for investors, as…

  • First Seacoast Bancorp (FSEA) Merger Agreement Values Bank at $80.9M in All-Cash Deal

    First Seacoast Bancorp (FSEA) Merger Agreement Values Bank at $80.9M in All-Cash Deal

    The transaction offers a fixed cash payout to shareholders and reflects ongoing consolidation in community banking. First Seacoast Bancorp, Inc. (NASDAQ:FSEA) announced a merger agreement with Cambridge Financial Group in an all-cash transaction valued at approximately $80.9 million. For investors, the deal provides a defined exit price while highlighting continued consolidation trends among regional banks.…

  • Cellectar (CLRB) Phase 2b Data Shows Durable Responses in Waldenström Macroglobulinemia

    Cellectar (CLRB) Phase 2b Data Shows Durable Responses in Waldenström Macroglobulinemia

    Updated 12-month follow-up results may support regulatory progress for its lead oncology candidate. Cellectar Biosciences, Inc. (NASDAQ:CLRB) reported updated Phase 2b data from its CLOVER WaM study, showing durable responses for iopofosine I 131 in relapsed or refractory Waldenström macroglobulinemia (WM). For investors, the results may strengthen the company’s case for accelerated approval and highlight…

  • FTC Solar (FTCI) Q1 Earnings Show Revenue Decline as CEO Transition Signals Strategic Reset

    FTC Solar (FTCI) Q1 Earnings Show Revenue Decline as CEO Transition Signals Strategic Reset

    Weak quarterly performance contrasts with new leadership and expectations for growth recovery later in 2026. FTC Solar, Inc. (NASDAQ:FTCI) reported Q1 earnings marked by a sharp revenue decline and continued losses, alongside a CEO transition that could signal a shift in strategy. For investors, the update highlights near-term operational challenges but also introduces a potential…

  • IPG Photonics (IPGP) Q1 Earnings Show Revenue Growth but Margin Pressure and Profit Decline

    IPG Photonics (IPGP) Q1 Earnings Show Revenue Growth but Margin Pressure and Profit Decline

    Strong top-line growth was offset by weaker profitability, highlighting mixed trends for investors. IPG Photonics Corporation (NASDAQ:IPGP) reported Q1 earnings with revenue rising 17% year over year to $265.5 million, but profitability declined as margins compressed and net income fell sharply. For investors, the results point to solid demand for laser solutions, but also rising…

  • SKK Holdings (SKK) $258.8M Asset Acquisition of Rantizo Drone Assets Signals Strategic Shift

    SKK Holdings (SKK) $258.8M Asset Acquisition of Rantizo Drone Assets Signals Strategic Shift

    The transaction would transform SKK into a drone-platform operator targeting agriculture, emergency response, and commercial markets. SKK Holdings Limited (NASDAQ:SKK) announced a $258.8 million asset acquisition of Rantizo’s drone-based platform, marking a major strategic pivot beyond its traditional engineering business. For investors, the deal signals a potential repositioning into the fast-growing unmanned aerial systems sector,…

  • Regeneron (REGN) Dupixent Phase 4 Trial Results Show Improved Esophageal Function in EoE

    Regeneron (REGN) Dupixent Phase 4 Trial Results Show Improved Esophageal Function in EoE

    New clinical data reinforce Dupixent’s role in treating eosinophilic esophagitis and may support its long-term positioning in the indication. Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) reported Dupixent Phase 4 trial results showing significant improvements in esophageal function and structural disease markers in eosinophilic esophagitis (EoE). The data, presented at Digestive Disease Week 2026, may strengthen confidence in…

  • Micron (MU) 245TB SSD Launch Signals Shift in Data Center Storage Economics

    Micron (MU) 245TB SSD Launch Signals Shift in Data Center Storage Economics

    The new high-capacity SSD targets AI and cloud workloads, potentially reshaping storage efficiency and infrastructure costs. Micron Technology, Inc. (NASDAQ:MU) announced the 245TB SSD launch, confirming it is now shipping the Micron 6600 ION — the highest-capacity commercially available solid-state drive. For investors, the milestone highlights Micron’s push into AI-driven data center demand, where storage…

  • Sow Good (SOWG) Secures $20M Credit Facility to Fund Critical Minerals Strategy Transition

    Sow Good (SOWG) Secures $20M Credit Facility to Fund Critical Minerals Strategy Transition

    The financing provides flexible capital as the company advances its proposed graphite project acquisition and shift into battery materials. Sow Good Inc. (NASDAQ:SOWG) announced it has executed a term sheet for a $20 million credit facility in a private placement with Sagol Advisors, aimed at funding its transition into critical minerals and battery anode materials.…